All Viruses articles – Page 25
-
NewsJessica Kahn named Senior Associate Dean for Clinical and Translational Research at Albert Einstein College of Medicine
After an extensive national search, Jessica Kahn, M.D., M.P.H., has been appointed as the senior associate dean for clinical and translational research and director of the Block Institute for Clinical and Translational Research (ICTR) at Albert Einstein College of Medicine. Source: Cincinnati Children’s Hospital Jessica Kahn, M.D., M.P.H., ...
-
NewsScientists prioritize 6 key pathogens for wastewater surveillance ahead of the Paris 2024 Olympic and Paralympic Games
French health authority researchers have identified priority pathogens that could be suitable for wastewater surveillance (WWS) during the Paris 2024 Olympic and Paralympic Games taking place from 26 July to 11 August and 28 August to 8 September.
-
NewsMayaro and chikungunya viruses observed circulating at the same time in the Brazilian Amazon
Infection by one virus was expected to afford protection against the other, preventing co-circulation. Researchers are warning of the risk of transmission of Mayaro in urban areas due to deforestation and advocate more effective epidemiological surveillance.
-
NewsReinfections from the virus that causes COVID-19 likely have similar severity to original infection
Researchers have found that severe infections from the virus that causes COVID-19 tend to foreshadow similar severity of infection the next time a person contracts the disease.
-
NewsNanoparticle vaccines enhance cross-protection against influenza viruses
To offer cross-protection against diverse influenza virus variants, nanoparticle vaccines can produce pivotal cellular and mucosal immune responses that enhance vaccine efficacy and broaden protection, a new study reveals.
-
NewsWHO prequalifies the first self-test for hepatitis C virus
The World Health Organization (WHO) has prequalified the first hepatitis C virus (HCV) self-test which can provide a critical support in expanding access to testing and diagnosis, accelerating global efforts to eliminate hepatitis C.
-
News‘Sacrifice’ of virus data clears the path to open a disease discovery pipeline
Researchers are analysing viruses in human populations – and on coral reefs – to build a robust method of identifying viruses in all animals, plants and environments, and to show the flexibility of the pipeline for future research.
-
NewsHepatitis C leaves ‘scars’ in immune cells even after successful treatment
Researchers have discovered that traces of ‘epigenetic scars’ remain in regulatory T cells and exhibit sustained inflammatory properties long after the Hepatitis C virus is cleared from the body.
-
NewsResearchers develop noninvasive urine test for early detection of cervical cancer virus proteins
A new urine test can detect HPV16 E7 proteins, which are critical markers of cervical cancer risk, at extremely low levels, meaning women may be able to screen for cervical cancer without the discomfort and inconvenience of a traditional Pap test.
-
NewsRaw milk is risky, but airborne transmission of H5N1 from cow’s milk is inefficient in mammals
New research suggests that exposure to raw milk infected with the currently circulating virus poses a real risk of infecting humans, but that the virus may not spread very far or quickly to others.
-
NewsNew bio-based tool quickly detects concerning coronavirus variants
Researchers have developed a bioelectric device that can detect and classify new variants of coronavirus to identify those that are most harmful. It has the potential to do the same with other viruses, as well.
-
NewsPhage‐display tech boosts targeting ability of antimicrobial peptides against Staphylococcus aureus
Antibiotics are widely used in clinical treatment and animal production as an effective means to combat microbial infections. Antimicrobial peptides, as potential alternatives to antibiotics, have shown promising applications. Source: CDC/ Matthew J. Arduino/ Janice Haney Carr Under a very high magnification of 20,000x, this scanning electron micrograph ...
-
NewsScientists uncover molecular basis of how potential anti-Covid drug binds to viral N-glycan
Researchers evaluating the potential of naturally occurring pradimicin A (PRM-A) as a new anti-SARS-CoV-2 drug that suppresses SARS-CoV-2 transmission investigated how exactly PRM-A binds to the viral N-glycans.
-
NewsDengue linked to heightened short- and long-term risk of depression in Taiwan
Analysis of the medical records of nearly 50,000 people who experienced dengue fever in Taiwan suggests that this disease is associated with elevated short- and long-term risk of depression.
-
NewsPasteurization inactivates highly infectious avian flu in milk
Researchers tested nearly 300 milk products from 132 processors in the US and found no infectious H5N1 virus in the samples.
-
NewsPublic fails to appreciate risk of consuming raw milk, survey finds
Fewer than half of U.S. adults know that drinking raw milk is less safe than drinking pasteurized milk and many Americans do not understand the risks of consuming raw milk, according to a new health survey.
-
NewsNew lab test to detect persistent HIV strains in Africa may aid search for cure
A multinational team has developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa—a vital tool in the search for an HIV cure that will benefit patients around the world.
-
NewsRecombinHunt: predicting new pandemics through data analysis
A study presents the promising results of RecombinHunt, a new data-driven method which can identify, with high accuracy and computational efficiency, recombinant SARS-CoV-2 genomes with one or two breakpoints.
-
NewsRevealed: new factor associated with the risk of severe COVID-19 in people with obesity
By analyzing samples from obese non-diabetics, researchers found that high blood levels of saturated fatty acids cause pre-activation of innate immune cells that, when infected with SARS-CoV-2, produce elevated levels of inflammatory molecules.
-
NewsBreakthrough research makes cancer-fighting viral agent more effective
Researchers from Aarhus University have made a significant breakthrough by discovering that the drug 4-OI can enhance the effectiveness of a cancer-fighting viral agent. This may lead to treatment of cancers that are otherwise resistant to therapies.